Neuromuscular Disorders
Conference Coverage
Researchers identify common reasons for misdiagnosis of ALS
AUSTIN – Particular clinical presentations and cognitive biases are associated with misdiagnosis of patients who...
Conference Coverage
Which patients are most likely to have a positive RNS test for myasthenia gravis?
AUSTIN, TEX. – The diagnostic yield of the test may be highest in patients with MGFA Class III or higher who are...
Conference Coverage
Study examines utility of repeat outpatient electrodiagnostic testing
AUSTIN, TEX. – Repeat testing for the same indication may not change symptom or disease management in about one-third of cases, a preliminary...
Conference Coverage
Neurologists consider flu shot safe in most patients with autoimmune neuromuscular disorders
AUSTIN, TEX. – Neurologists are circumspect about recommending influenza vaccination for patients with a history of...
Conference Coverage
Placebo response in negative rituximab BeatMG trial provides important lessons
AUSTIN, TEX. – The BeatMG trial offers clues and reinforces the need for placebo-controlled studies, Dr. Richard Nowak said.
Conference Coverage
Congenital myasthenic syndrome diagnosed best with repetitive stimulation and jitter analysis
Nearly 14% of patients with congenital myasthenic syndrome would be missed if tested with jitter analysis but not repetitive stimulation.
Conference Coverage
Late response to eculizumab may occur in minority of myasthenia gravis patients
AUSTIN – Most patients respond to treatment within 12 weeks, but others respond after longer periods of therapy.
Literature Review
Neurologists publish consensus statement on stridor in MSA
The statement provides guidance on the diagnosis, prognosis, and treatment of stridor in patients with MSA, as well as indicating areas for future...
From the Journals
Viral cause of acute flaccid myelitis eludes detection
Acute flaccid myelitis shows a viral etiology but analysis of specimens from affected individuals fails to identify a single viral cause.
Conference Coverage
Coming soon!
Literature Review
Can a novel steroidal anti-inflammatory drug benefit patients with Duchenne muscular dystrophy?
Vamorolone may reduce “safety concerns typically seen with traditional glucocorticoids,” researchers said.